Pharmacy cost evaluation of risperidone, olanzapine, and quetiapine for the treatment of schizophrenia in acute care inpatient settings. [electronic resource]
Producer: 20050419Description: 1883-93 p. digitalISSN:- 0300-7995
- Adult
- Antipsychotic Agents -- economics
- Benzodiazepines -- economics
- Costs and Cost Analysis
- Dibenzothiazepines -- economics
- Drug Costs -- statistics & numerical data
- Female
- Humans
- Inpatients
- Male
- Mental Health Services -- statistics & numerical data
- Middle Aged
- Olanzapine
- Quetiapine Fumarate
- Retrospective Studies
- Risperidone -- economics
- Schizophrenia -- drug therapy
No physical items for this record
Publication Type: Comparative Study; Evaluation Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.